SCHEMBL15026352

SCHEMBL15026352

O=C1c2ccc(F)cc2C(=O)c2oc(S(=O)(=O)C(F)(F)F)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 1/20 0.35
USP7 Q93009 1/20 0.35
USP47 Q96K76 1/20 0.35
ALDH1A1 P00352 2/20 0.34
STAT3 P40763 2/20 0.34
EPAS1 Q99814 1/20 0.34
MALT1 Q9UDY8 1/20 0.34
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
USP1 O94782 1/20 0.31
USP19 O94966 1/20 0.31
UCHL3 P15374 1/20 0.31
IDO1 P14902 2/20 0.30
TDO2 P48775 2/20 0.30
PTGS2 P35354 1/20 0.30
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45647 0.85 STAT3 (0.47) USP8USP7ALDH1A1STAT3USP1
SCHEMBL45711 0.82 PTGS2 (0.39) USP8USP7USP47ALDH1A1STAT3
SCHEMBL45702 0.80 MAPT (0.38) ALDH1A1STAT3USP1USP19UCHL3
SCHEMBL15024455 0.76 TLR9 (0.38) ALDH1A1CA2PTGS2
SCHEMBL19668949 0.73 STAT3 (0.41) USP8USP7USP47ALDH1A1STAT3
SCHEMBL45738 0.72 ALDH1A1 (0.33) USP8USP7USP47ALDH1A1STAT3
SCHEMBL9328908 0.72 CA1 (0.52) USP8USP7USP47ALDH1A1MALT1
SCHEMBL3715764 0.72 STAT3 (0.54) USP8USP7USP47ALDH1A1STAT3
SCHEMBL12640083 0.71 ALDH1A1 (0.36) USP8USP7USP47ALDH1A1STAT3
SCHEMBL12640078 0.71 ALDH1A1 (0.39) USP8USP7USP47ALDH1A1STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871802-B2 Naphthoquinones for disease therapies ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2014-10-28 US disclosed
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES NQO1, NME2, CYP27B1 USP8 4421/4885USP7 4665/4885USP47 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.